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worse response to antiviral therapy in women affected by
chronic hepatitis C
We read with great interest the article entitled ‘‘Impact of sex
on virologic response rates in genotype 1 chronic hepatitis C
patients with peg-interferon alpha-2a and ribavirin treatment’’.1 It
was shown that in women affected by chronic hepatitis C and
treated with antiviral therapy, the sustained virological response
(SVR) rate decreases with age as a likely consequence of gradual
estrogen decline. Moreover, it was reported that among young
patients, SVR is higher in females than in males, while in older
subjects the opposite occurs.
Although the data reported are interesting, we would like to
make some comments. First of all, the choice to select a priori
patients with genotype 1 produces a selection bias, as genotype 1
infection is universally known to be associated with resistance to
interferon, and thus the population was not representative of all
hepatitis C virus (HCV) females. Moreover, we found extremely
interesting the clear-cut difference in SVR according to the three
age categories chosen (<40 years, 40–50 years, and 50–60 years),
with SVR decreasing in females from the first category to the last
one. We think that this fits, with astonishing accuracy, the data
recently published by our group on the effect of menopause in
HCV-positive women.2 Indeed, the last category described by Yu
et al. (age 50–60 years) most likely includes almost only
menopausal women. In this regard, our finding applies to all
menopausal women, although the effect is most evident in those
with genotype 1.
We believe that menopause and not age is the key factor in
determining the lack of response to antiviral therapy. We have
demonstrated that cytokine dosage and immunohistochemical
assessment of tumor necrosis factor alpha (TNF-a) and suppressor
of cytokine signaling 3 (SOCS3), dramatically increase in women
after the menopause in comparison with women of reproductive
age. Our data suggest that the early menopause (estrogen
deprivation <5 years) is associated with an up-regulation of
hepatic TNF-a and SOCS3 together with a marked increase in1201-9712/$36.00 – see front matter  2011 International Society for Infectious Disea
doi:10.1016/j.ijid.2011.09.025circulating interleukin 6 (IL-6), whose levels correlate with higher
necro-inflammation; its postmenopausal rise is associated with
the progression of fibrosis and with worsened necro-inflammation.
The levels of the analyzed cytokines progressively decrease
after the menopause and, over time, the hepatic expression of
TNF-a becomes comparable to that of women of reproductive
age. This also occurs in younger women who undergo surgical
menopause.
These modifications are causally linked with the occurrence of
resistance to the action of interferon and therefore explain the
progressively lower SVR rate in women: menopause and not age is
the critical factor.
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